AstraZeneca United States
Commitment to mental health. Learn about help available for people living with mental illness and those who care about them. Learn moreHealthcare for people. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
-
News
-
May 8, 2008
:
AstraZeneca submits sNDA for SEROQUEL XR™ for the treatment of generalized anxiety disorder – a first for the atypical antipsychotic class of medicines
-
May 5, 2008
:
New data on SEROQUEL XR™ in treatment of both major depressive disorder and generalized anxiety disorder presented at APA Annual Meeting
-
Apr 30, 2008
:
AstraZeneca submits an sNDA for SYMBICORT® for COPD indication
-
May 8, 2008
:
AstraZeneca submits sNDA for SEROQUEL XR™ for the treatment of generalized anxiety disorder – a first for the atypical antipsychotic class of medicines
-
Site features
- Community Support Learn about the community-based programs we support that emphasize disease education and improved access to healthcare
- Help Affording Your Medicines Learn about AstraZeneca programs that can help make medicines more affordable
- Who is AstraZeneca? Watch this short video to learn who we are and what we do
